At ASHM, we arm practitioners with contemporary evidence-based research and best practice in preventing and reducing the risk of HIV transmission. This includes providing resources such as the Australian Contact Tracing Manual, and the National Testing Portal. ASHM is also involved in developing Australian guidelines around Post-exposure Prophylaxis (PEP) and Pre-exposure Prophylaxis (PrEP).
PEP is the gold standard occupational and non-occupational prevention method in a limited number of circumstances. It is made available through state and territory governments. It is not currently funded under the Pharmaceutical Benefits Scheme (PBS).
In 2016, ASHM produced the National Guidelines for Post-Exposure Prophylaxis after Occupational and Non-Occupational exposure to HIV which provides clinical guidance on the drugs of choice, protocols for testing the possible source and referral information. Development of these Guidelines was done with support of a grant from the Australian Government, Department of Health.
PrEP is a preventative method by which an individual takes a dose of antiretrovirals before a possible risk exposure to reduce their risk of acquiring HIV infection.
PrEP is currently not approved by the Therapeutic Goods Administration (TGA) or listed under the PBS. Pilot studies are being conducted in Brisbane, Melbourne and Sydney to evaluate PrEP in the Australian context.
ASHM, through the Antiretroviral Guidance Committee (ARVG), has worked closely with the demonstration projects to develop an Australian Commentary on the USA CDC PrEP Guidelines.